CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −2,566 | $8.00 | $21K | 123,781 |
| 2026-09-30 | Calkins Daniel Chief Financial Officer | Grant or award 10b5-1 | −8,333 | 126,347 | ||
| 2026-09-21 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −55 | $7.70 | $424 | 118,014 |
| 2026-06-22 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −4,032 | $4.18 | $17K | 117,295 |
| 2026-06-22 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −57 | $4.13 | $235 | 117,238 |
| 2026-03-20 | Calkins Daniel Chief Financial Officer | Grant or award 10b5-1 | −57 | $5.74 | $327 | 121,327 |
| 2026-01-21 | Calkins Daniel Chief Financial Officer | Grant or award | +16,665 | 121,384 | ||
| 2026-01-12 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −5,039 | $7.16 | $36K | 104,719 |
| 2025-12-24 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −80 | $7.86 | $629 | 109,758 |
| 2025-09-24 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −25 | $9.23 | $231 | 109,838 |
| 2025-09-22 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −57 | $9.08 | $518 | 109,863 |
| 2025-06-23 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −25 | $4.71 | $118 | 109,920 |
| 2025-06-20 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −4,110 | $5.13 | $21K | 109,945 |
| 2025-05-20 | Calkins Daniel Chief Financial Officer | Sale 10b5-1 | −11,143 | $8.13 | $91K | 114,055 |
| 2025-05-16 | Calkins Daniel Chief Financial Officer | Grant or award 10b5-1 | −38,850 | 125,198 | ||
| 2025-03-24 | Calkins Daniel Chief Financial Officer | Sale | −26 | $7.04 | $183 | 86,348 |
| 2025-03-20 | Calkins Daniel Chief Financial Officer | Sale | −65 | $6.89 | $448 | 86,374 |
| 2025-01-10 | Calkins Daniel Chief Financial Officer | Grant or award | +38,800 | 86,439 | ||
| 2025-01-06 | Calkins Daniel Chief Financial Officer | Sale | −6 | $6.94 | $42 | 47,639 |
| 2024-12-24 | Calkins Daniel Chief Financial Officer | Sale | −28 | $3.91 | $109 | 47,368 |
Page 1 of 3 · 53 trades